FDA
approval
· 2016-05-20
FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for INVOKANA (canagliflozin) submitted by Janssen Pharmaceuticals, Inc.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for INVOKANA (CANAGLIFLOZIN)